Matthew C Kapusta Uni Qure N.V. (QURE) insider trading activity

Matthew C Kapusta is CEO, Managing Director of uniQure N.V.. Currently has a direct ownership of 590,839 shares of QURE, which is worth approximately $5.06 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 150,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 591K

0% 3M change

26.05% 12M change

Total Value Held $5.06 Million

Matthew C Kapusta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	BUY Grant, award, or other acquisition	-	150,000 Added 20.25%	590,839 Ordinary Shares
Feb 26 2024	SELL Open market or private sale	$177,190 $6.35 p/Share	27,904 Reduced 5.95%	440,839 Ordinary Shares
Mar 07 2023	SELL Open market or private sale	$53,924 $21.39 p/Share	2,521 Reduced 0.53%	468,743 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$104,938 $20.9 p/Share	5,021 Reduced 1.05%	471,264 Ordinary Shares
Feb 27 2023	SELL Open market or private sale	$391,496 $20.05 p/Share	19,526 Reduced 3.94%	476,285 Ordinary Shares
Feb 23 2023	BUY Grant, award, or other acquisition	-	121,500 Added 19.68%	495,811 Ordinary Shares
Feb 20 2023	BUY Grant, award, or other acquisition	-	5,830 Added 1.53%	374,311 Ordinary Shares

Dec 09 2022	SELL Open market or private sale	$149,181 $22.44 p/Share	6,648 Reduced 1.77%	368,481 Ordinary Shares
Nov 22 2022	BUY Grant, award, or other acquisition	-	14,575 Added 3.74%	375,129 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$170,257 $16.7 p/Share	10,195 Reduced 2.75%	360,554 Ordinary Shares
Feb 24 2022	BUY Grant, award, or other acquisition	-	125,073 Added 25.23%	370,749 Ordinary Shares
Jan 26 2022	SELL Open market or private sale	$197,308 $18.1 p/Share	10,901 Reduced 4.25%	245,676 Ordinary Shares
Aug 18 2021	SELL Open market or private sale	$28,360 $28.36 p/Share	1,000 Reduced 0.39%	256,577 Ordinary Shares
Jul 14 2021	SELL Open market or private sale	$27,770 $27.77 p/Share	1,000 Reduced 0.39%	257,577 Ordinary Shares
Jun 17 2021	SELL Open market or private sale	$66,500 $35.0 p/Share	1,900 Reduced 0.73%	258,577 Ordinary Shares
Jun 16 2021	SELL Open market or private sale	$119,266 $34.57 p/Share	3,450 Reduced 1.31%	260,477 Ordinary Shares
May 12 2021	SELL Open market or private sale	$72,653 $32.29 p/Share	2,250 Reduced 0.85%	263,927 Ordinary Shares
Apr 14 2021	SELL Open market or private sale	$189,016 $35.33 p/Share	5,350 Reduced 1.97%	266,177 Ordinary Shares
Mar 17 2021	SELL Open market or private sale	$76,095 $33.82 p/Share	2,250 Reduced 0.82%	271,527 Ordinary Shares
Mar 02 2021	SELL Open market or private sale	$183,740 $36.94 p/Share	4,974 Reduced 1.78%	273,777 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	55,813 Added 16.68%	278,751 Ordinary Shares
Feb 15 2021	SELL Open market or private sale	$134,634 $35.43 p/Share	3,800 Reduced 1.68%	222,938 Ordinary Shares
Jan 29 2021	SELL Open market or private sale	$250,880 $35.84 p/Share	7,000 Reduced 2.99%	226,738 Ordinary Shares
Jan 28 2021	SELL Open market or private sale	$573,457 $36.41 p/Share	15,750 Reduced 6.31%	233,738 Ordinary Shares
Jan 28 2021	SELL Open market or private sale	$573,457 $36.41 p/Share	15,750 Reduced 6.31%	233,738 Ordinary Shares

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

MCK